Abstract as per original application
(English/Chinese): |
This research project will generate the first study on critical care among psychedelic medicine practices in Australia. In June 2023, Australia’s drug regulators set a global precedent by recognizing psychedelic substances, such as psilocybin and ayahuasca, as registered psychiatric medicines. Known for deeply altering mood, perception, and sense of self, the drugs are receiving increasing investment with the global market projected to grow significantly over the next decade. While extensive research exists on spatial and environmental aspects of other healthcare settings, psychedelic medicine remains unexplored in these areas, despite that the drugs dramatically alter perceptions of space, objects, and environments. The project will address how patients encounter the epistemic and moral significance of space and materialities of care in psychedelic treatments in Australia, offering critical insights for healthcare providers, academic researchers, and policy makers navigating similar terrains. The project will be useful to stakeholders in Australia and in the bourgeoning global field that the country is now poised to help lead, following its sudden regulatory changes.
Concerns exist over the extreme vulnerability and suggestibility of patients during the drug treatments, as they undergo intense mood shifts, altered sensory perceptions, and sometimes enduring changes in metaphysical beliefs. The role of treatment environments in shaping the epistemic and moral dimensions of belief change during psychedelic healing necessitates analysis. This study will provide theoretical and methodological advances and fresh data that can engage epistemic concerns and therapeutic benefits of these new psychiatric treatments.
How does symbolism and art in the clinics impact patient experiences? What meaning do patients and carers make about the treatment objects, spaces, and environments? How do biophilic or “natural” qualities influence patient perception? Finally, what epistemic and moral roles do materialities of care take across spatial and environmental dimensions for these drug-assisted psychotherapies? This project will combine methods of qualitative interviews, ethnographic observation, and sensory analysis to: (1) analyze the interface between patient psychological vulnerability, belief changes, and moralized views of the treatment spaces, (2) theorize how these perception-altering drug treatments can elucidate issues of space in psychiatric care settings more broadly, (3) increase dialogue between critical medical humanities and psychiatry and psychotherapy regarding sensory and material aspects of care, and (4) produce two high-impact journal articles and one ethnographic monograph. These project outputs will help to support ethical practices by understanding potential epistemic harms of new treatments that have promising evidence of clinical benefit.
“这个研究将产生有关澳大利亚迷幻药医学照护实践的首项研究。2023年6月，澳大利亚药品监管机构开创了全球先例，承认裸盖菇素和死藤水等致幻物质为注册精神科药物。这些药物以深刻地改变情绪、感知和自我意识而闻名，相关的全球市场预计在未来十年内将显著增长，因此受到越来越多的投资。虽然与医疗空间/环境相关的研究已经广泛存在，但迷幻药物在这些方面仍然未被探索，尽管这些药物显著地改变了空间、物体和环境的感知。该项目将探讨患者在澳大利亚迷幻治疗中面对空间和照护的物质性的认识论和道德意义，为医疗保健提供关键见解，为学术研究人员和政策制定者在类似领域中提供指导。在监管政策变化的背景下，该项目将对澳大利亚的利益相关者以及该国准备带头领导的蓬勃发展的全球领域具有实用价值。
在药物治疗期间，患者处于极度脆弱和易受影响的状态，他们经历强烈的情绪变化、感觉知觉的改变，有时还会出现持久的形而上学信仰变化，这引发了人们的关切。治疗环境在塑造迷幻治疗中信仰变化的认知和道德维度方面的作用需要被进一步分析。这项研究将提供理论和方法上的进步以及新的数据，以探讨这些新型精神疗法的认知关注和治疗益处。
临床中的象征和艺术对患者体验有何影响？患者和护理人员对治疗物品、空间和环境赋予的意义是什么？亲生物设计或“自然”的特性如何影响患者的感知？最后，在这些药物辅助心理治疗中，照护的物质性在空间和环境维度上扮演什么认识论的和道德的角色？该项目将结合定性访谈、民族志观察和感官分析方法，以：（1）分析患者心理脆弱性、信仰变化和治疗空间的道德化视角之间的界面，（2）理论化这些改变感知的药物治疗如何更广泛地阐明精神卫生照护环境中的空间问题，（3）促进医学人文领域和精神病学与心理治疗之间在照护的感官和物质性方面的对话，（4）产生两篇高影响力的期刊文章和一篇民族志专著。这些项目成果将有助于通过了解具有临床益处的新治疗可能存在的认知危害来支持道德实践。”
|
